Xtx Topco LTD Regeneron Pharmaceuticals, Inc. Transaction History

Xtx Topco LTD

$1.3 Billion
Q3 2024

A detailed history of Xtx Topco LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 806 shares of REGN stock, worth $596,448. This represents 0.07% of its overall portfolio holdings.

Number of Shares

806

Previous 1,057 23.75%

Holding current value

$596,448

Previous $1.11 Million 23.69%

% of portfolio

0.07%

Previous 0.1%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $257,046 - $301,641	-251 Reduced 23.75%	806 $847,000
Q2 2024 Aug 12, 2024	SELL	$883.2 - $1071.19 $2.09 Million - $2.53 Million	-2,364 Reduced 69.1%	1,057 $1.11 Million
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $1.51 Million - $1.66 Million	1,671 Added 95.49%	3,421 $3.29 Million
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $562,780 - $640,114	726 Added 70.9%	1,750 $1.54 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $709,068 - $864,634	1,024 New	1,024 $842,000
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $1.61 Million - $1.96 Million	2,369 Added 281.69%	3,210 $2.64 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $593,653 - $644,533	841 New	841 $606,000
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $166,698 - $224,607	-304 Reduced 15.45%	1,664 $984,000
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $1.17 Million - $1.37 Million	1,968 New	1,968 $1.37 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $1.08 Million - $1.28 Million	-1,876 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$472.8 - $558.54 $210,868 - $249,108	446 Added 31.19%	1,876 $1.05 Million
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $638,823 - $783,926	1,430 New	1,430 $677,000

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account